IL122482A - Methods for stably incorporating substances within dry foamed glass matrices and compositions obtained thereby - Google Patents

Methods for stably incorporating substances within dry foamed glass matrices and compositions obtained thereby

Info

Publication number
IL122482A
IL122482A IL12248296A IL12248296A IL122482A IL 122482 A IL122482 A IL 122482A IL 12248296 A IL12248296 A IL 12248296A IL 12248296 A IL12248296 A IL 12248296A IL 122482 A IL122482 A IL 122482A
Authority
IL
Israel
Prior art keywords
methods
compositions obtained
foamed glass
stably incorporating
dry foamed
Prior art date
Application number
IL12248296A
Other languages
English (en)
Other versions
IL122482A0 (en
Original Assignee
Quadrant Holdings Cambridge
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23930384&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL122482(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Quadrant Holdings Cambridge filed Critical Quadrant Holdings Cambridge
Publication of IL122482A0 publication Critical patent/IL122482A0/xx
Publication of IL122482A publication Critical patent/IL122482A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Glass Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL12248296A 1995-06-07 1996-06-07 Methods for stably incorporating substances within dry foamed glass matrices and compositions obtained thereby IL122482A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48604395A 1995-06-07 1995-06-07
PCT/GB1996/001367 WO1996040077A2 (en) 1995-06-07 1996-06-07 Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby

Publications (2)

Publication Number Publication Date
IL122482A0 IL122482A0 (en) 1998-06-15
IL122482A true IL122482A (en) 1999-10-28

Family

ID=23930384

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12248296A IL122482A (en) 1995-06-07 1996-06-07 Methods for stably incorporating substances within dry foamed glass matrices and compositions obtained thereby

Country Status (22)

Country Link
EP (1) EP0831790B1 (zh)
JP (1) JP4502406B2 (zh)
KR (1) KR19990022710A (zh)
CN (1) CN1245957C (zh)
AP (1) AP852A (zh)
AT (1) ATE239451T1 (zh)
AU (1) AU713599B2 (zh)
BR (1) BR9609188A (zh)
CA (1) CA2223438C (zh)
CZ (1) CZ391297A3 (zh)
DE (1) DE69628007T2 (zh)
DK (1) DK0831790T3 (zh)
ES (1) ES2194992T3 (zh)
HU (1) HUP9901716A3 (zh)
IL (1) IL122482A (zh)
MX (1) MX9709716A (zh)
NO (1) NO975773L (zh)
NZ (1) NZ309841A (zh)
PL (1) PL184823B1 (zh)
PT (1) PT831790E (zh)
SK (1) SK167597A3 (zh)
WO (1) WO1996040077A2 (zh)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1188171C (zh) 1994-06-02 2005-02-09 廓德伦特控股剑桥有限公司 防止各种特质在再水化或熔化时聚集的方法以及由此获得的组合物
US6964771B1 (en) 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
US6509146B1 (en) 1996-05-29 2003-01-21 Universal Preservation Technologies, Inc. Scalable long-term shelf preservation of sensitive biological solutions and suspensions
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
GB9705588D0 (en) 1997-03-18 1997-05-07 Anglia Research Foundation Stable particle in liquid formulations
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
AU5459698A (en) * 1997-11-26 1999-06-15 Universal Preservation Technologies, Inc. Preservation of sensitive biological samples by vitrification
US6352722B1 (en) 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
EP1071465A1 (en) * 1998-03-18 2001-01-31 Ronai, Peter Amorphous glasses for stabilising sensitive products
US6306345B1 (en) * 1998-05-06 2001-10-23 Universal Preservation Technologies, Inc. Industrial scale barrier technology for preservation of sensitive biological materials at ambient temperatures
GB9904049D0 (en) * 1999-02-22 1999-04-14 Quadrant Holdings Cambridge Rapidly-soluble compositions
JP2011025068A (ja) * 1999-02-22 2011-02-10 Chugai Pharmaceut Co Ltd プレフィルドシリンジタンパク質溶液製剤
EA004131B1 (ru) * 1999-05-04 2003-12-25 Энхайдро Лимитед Способ сохранения вирусов и микоплазмы
US6692695B1 (en) 1999-05-06 2004-02-17 Quadrant Drug Delivery Limited Industrial scale barrier technology for preservation of sensitive biological materials
GB9914412D0 (en) * 1999-06-22 1999-08-18 Worrall Eric E Method for the preservation of viruses,bacteria and biomolecules
EP1402003A4 (en) * 1999-08-19 2004-07-14 Universal Preservation Technologies Inc STORAGE OF AMBIENT TEMPERATURE BACTERIAL CELLS
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
SI1296656T1 (sl) * 2000-06-27 2006-12-31 Hoffmann La Roche Postopek priprave sestavka
GB0017999D0 (en) * 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
US6653062B1 (en) 2000-07-26 2003-11-25 Wisconsin Alumni Research Foundation Preservation and storage medium for biological materials
US6537666B1 (en) 2000-10-23 2003-03-25 Universal Preservation Technologies, Inc. Methods of forming a humidity barrier for the ambient temperature preservation of sensitive biologicals
JP2005508992A (ja) * 2001-11-09 2005-04-07 セントカー・インコーポレーテツド 凍結乾燥されたモノクローナル抗体組成物
WO2003053411A1 (en) 2001-12-19 2003-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
EP1556477B1 (en) * 2002-11-01 2017-08-09 GlaxoSmithKline Biologicals s.a. Drying process
EP1428526A1 (en) * 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Formulation for fast dissolution of lipophilic compounds
GB0409795D0 (en) * 2004-04-30 2004-06-09 Glaxosmithkline Biolog Sa Drying method
EP2168975A3 (en) 2004-05-24 2012-01-11 Genvault Corporation Method of stably storing biomolecules in recoverable form
PL1750760T3 (pl) 2004-06-02 2018-02-28 Universal Stabilization Technologies, Inc. Konserwacja za pomocą parowania
GB0517688D0 (en) * 2005-08-31 2005-10-05 Cambridge Biostability Ltd Improvements in the stabilisation of biological materials
GB0523638D0 (en) 2005-11-21 2005-12-28 Cambridge Biostability Ltd Pharmaceutical device for the administration of substances to patients
ES2470340T3 (es) 2005-12-28 2014-06-23 Advanced Bionutrition Corporation Vehículo de administración para bacterias probi�ticas que comprende una matriz seca de polisac�ridos, sac�ridos y polioles en forma vítrea
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
JP5285617B2 (ja) 2006-12-18 2013-09-11 アドバンスド バイオニュートリション コーポレーション 生きたプロバイオティクスを含む乾燥食物製品
CN105147611A (zh) 2007-07-26 2015-12-16 圣诺菲·帕斯图尔有限公司 抗原佐剂组合物及其方法
WO2010031007A2 (en) 2008-09-12 2010-03-18 Genvault Corporation Matrices and media for storage and stabilization of biomolecules
US9623094B2 (en) 2009-03-27 2017-04-18 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
MX2011012586A (es) 2009-05-26 2012-03-26 Advanced Bionutrition Corp Composicion de polvo seco estable que comprende microorganismos biologicamente activos y/o materiales bioactivos y metodos de elaboracion.
GB0918450D0 (en) 2009-10-21 2009-12-09 Innovata Ltd Composition
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
RU2535869C2 (ru) 2010-01-28 2014-12-20 Эдванст Бионутришн Корпорейшн Сухая стекловидная композиция для стабилизации и защиты биологически активного материала и способ ее получения
DK2603100T3 (en) 2010-08-13 2018-08-06 Advanced Bionutrition Corp DRY STABILIZING COMPOSITION FOR STORAGE OF BIOLOGICAL MATERIALS
CA2828248A1 (en) * 2011-02-24 2012-08-30 Paxvax, Inc. Formulations useful for spray drying vaccines
WO2012158978A1 (en) * 2011-05-17 2012-11-22 Soligenix, Inc. Thermostable vaccine compositions and methods of preparing same
US20140302021A1 (en) 2011-10-25 2014-10-09 Onclave Therapeutics Limited Antibody formulations and methods
GB2498774A (en) * 2012-01-27 2013-07-31 Bruce Roser Glass-stabilised biological materials and syringe
CN108347982A (zh) 2015-07-29 2018-07-31 高级生物营养公司 用于特殊饮食用途的稳定的干燥益生菌组合物
US11266337B2 (en) * 2015-09-09 2022-03-08 Drawbridge Health, Inc. Systems, methods, and devices for sample collection, stabilization and preservation
CN106434840B (zh) * 2016-12-02 2019-08-09 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测维生素b12的微孔板、其试剂盒及其制备方法
CN106701887B (zh) * 2017-01-03 2020-01-17 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测叶酸的微孔板、其试剂盒及其制备方法
CN106676160B (zh) * 2017-01-03 2020-02-21 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测泛酸的微孔板、其试剂盒及其制备方法
CN106676161B (zh) * 2017-01-03 2020-01-21 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测烟酸的微孔板、其试剂盒及其制备方法
CN106591415B (zh) * 2017-01-03 2019-12-10 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测生物素的微孔板、其试剂盒及其制备方法
SG11201906247WA (en) 2017-01-10 2019-08-27 Drawbridge Health Inc Devices, systems, and methods for sample collection
CN117050969B (zh) * 2023-08-18 2024-04-02 北京中检葆泰生物技术有限公司 一种碱性磷酸酶的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362830A (en) * 1966-04-04 1968-01-09 American Mach & Foundry Preparation of water soluble product
JPS57100177A (en) * 1980-12-16 1982-06-22 Showa Denko Kk Mixed agent composition of amino acid with saccharide
CA1258428A (en) * 1984-06-28 1989-08-15 Nalinkant C. Damani Antacid composition
GB8604983D0 (en) * 1986-02-28 1986-04-09 Biocompatibles Ltd Protein preservation
GB8801338D0 (en) * 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
CA2031191C (en) * 1989-05-01 1997-03-25 Julian P. Breillatt, Jr. Composition of beneficial agent and method for administering the same by controlled dissolution
DE3918051A1 (de) * 1989-06-02 1990-12-06 Haensel Otto Gmbh Verfahren zur satzweisen herstellung einer beluefteten suesswarenschaummasse aus einer zuckerloesung und einer aufschlagmittelloesung
GB9010742D0 (en) * 1990-05-14 1990-07-04 Quadrant Bioresources Ltd Stabilization of biological macromolecular substances
JPH06182189A (ja) * 1991-05-31 1994-07-05 Res Corp Technol Inc 自己乳化型ガラス
JP3164854B2 (ja) * 1991-10-31 2001-05-14 雪印乳業株式会社 皮膚衛生用シート
WO1993010758A1 (en) * 1991-12-05 1993-06-10 Pitman-Moore, Inc. A carbohydrate glass matrix for the sustained release of a therapeutic agent
WO1993013758A1 (en) * 1992-01-13 1993-07-22 Pfizer Inc. Preparation of tablets of increased strength
US5523106A (en) * 1994-02-03 1996-06-04 Nabisco, Inc. Juice-based expanded snacks and process for preparing them
CA2190598A1 (en) * 1994-05-27 1995-12-07 Lawrence John Penkler Pharmaceutical composition

Also Published As

Publication number Publication date
JPH11506467A (ja) 1999-06-08
AP9701151A0 (en) 1998-01-31
DK0831790T3 (da) 2003-09-01
AU713599B2 (en) 1999-12-09
KR19990022710A (ko) 1999-03-25
NO975773L (no) 1998-02-03
ATE239451T1 (de) 2003-05-15
NO975773D0 (no) 1997-12-08
CA2223438C (en) 2008-05-13
WO1996040077A2 (en) 1996-12-19
CZ391297A3 (cs) 1998-05-13
CA2223438A1 (en) 1996-12-19
CN1193908A (zh) 1998-09-23
BR9609188A (pt) 1999-05-11
DE69628007D1 (de) 2003-06-12
CN1245957C (zh) 2006-03-22
PL323902A1 (en) 1998-04-27
PT831790E (pt) 2003-07-31
EP0831790A2 (en) 1998-04-01
JP4502406B2 (ja) 2010-07-14
HUP9901716A2 (hu) 1999-09-28
HUP9901716A3 (en) 2000-04-28
ES2194992T3 (es) 2003-12-01
PL184823B1 (pl) 2002-12-31
WO1996040077A3 (en) 1997-01-23
AP852A (en) 2000-06-16
SK167597A3 (en) 1998-10-07
AU6009896A (en) 1996-12-30
NZ309841A (en) 1999-10-28
MX9709716A (es) 1998-03-31
IL122482A0 (en) 1998-06-15
DE69628007T2 (de) 2003-11-27
EP0831790B1 (en) 2003-05-07

Similar Documents

Publication Publication Date Title
IL122482A0 (en) Methods for stably incorporating substances within dry foamed glass matrices and compositions obtained thereby
EP0902834A4 (en) STABLE AVIDIN COMPOSITION AND METHODS OF USE THEREOF
AU7378798A (en) Solid porous matrices and methods of making and using the same
AU5590296A (en) Post-foamable foam composition
EP0553843A3 (en) Foamable silicone rubber composition
GB9508691D0 (en) Stable compositions
AU5979496A (en) Composition and methods for losing weight
HUP9900743A3 (en) Bituminous composition and using them
AU2436495A (en) Dry chocolate-flavored beverage mix
GB2318814B (en) Foamable gel composition
PL331423A1 (en) Muporocin and chlorohexidrin containing compositions
EP0848745A4 (en) FOAMING COMPOSITION
ZA965642B (en) Packaged foaming composition
HUP9600148A2 (en) Glass composition
IL120722A (en) Polysulfated tetrasaccharide derivatives and pharmaceutical compositions containing them
PL330820A1 (en) Novel radiopharmaceutic compositions and matrices and their application
EP0857207A4 (en) MICROPOROUS COMPOSITION KILLING PATHOGENS
AU6392896A (en) In situ blown foams
AU1259097A (en) Dry foamable composition and uses thereof
GB9526675D0 (en) Bituminous composition and process
EP0553842A3 (en) Foamable organosiloxane composition
HUP9904279A3 (en) Solid composition
AU7298296A (en) Lubeluzole n-oxide
PL310462A1 (en) Acetal containing mixture and application thereof
AU8682798A (en) High fructose containing insecticide compositions and methods of using the same

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees